Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population

NCT00621283 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped Poor patient enrollment due to logistical issues

Conditions

Acute Recurrent Pancreatitis
Chronic Pancreatitis

Interventions

DRUG: RG1068 (Synthetic Human Secretin)

Sponsor

Massachusetts General Hospital